Treatment of persistent chylothorax with somatostatin.
Matsuo
Takehiko
T
Matsumoto
Masahiko
M
Sugita
Takaaki
T
Nishizawa
Junichiro
J
Matsuyama
Katsuhiko
K
Tokuda
Yoshiyuki
Y
Yoshida
Kazunori
K
D000015:Abnormalities, Multiple / Q000175:diagnosis / Q000601:surgery*; D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007415:Intestinal Obstruction / Q000139:chemically induced* / Q000601:surgery; D011379:Prognosis; D011651:Pulmonary Artery / Q000002:abnormalities / Q000601:surgery; D011667:Pulmonary Veins / Q000002:abnormalities / Q000601:surgery; D012008:Recurrence; D018570:Risk Assessment; D013004:Somatostatin / Q000008:administration & dosage / Q000009:adverse effects*; D013154:Spleen / Q000002:abnormalities; D019616:Thoracic Surgical Procedures / Q000009:adverse effects* / Q000379:methods
D013004:Somatostatin